Science & Research
Scientific Breakthrough in Anti-Aging: Key Ingredients Show Promise
Recent dermatological research highlights five key ingredients—Matrixyl, Argireline, Volufiline, Retinol, and PDRN—that offer significant anti-aging benefits, addressing wrinkles, skin volume loss, and cellular senescence with minimal irritation.
Creative Biolabs' Cell Line Innovations Propel Antibody Therapy Advancements
Creative Biolabs' latest developments in cell line technology are revolutionizing antibody therapy, offering new hope for cancer treatment and biotech research.
Telomir Pharmaceuticals Reports Preclinical Success for Telomir-1 in Progeria Cell Lines
Telomir Pharmaceuticals' preclinical data shows Telomir-1's potential in preventing cellular aging in progeria cell lines, marking a significant advancement in treating Hutchinson-Gilford Progeria Syndrome (HGPS).
Soligenix's SGX302 Shows Promise in Psoriasis Treatment
Soligenix Inc.'s SGX302, a novel therapy for psoriasis, has demonstrated effectiveness and safety in Phase 2a trials, offering hope to millions affected by this autoimmune disorder.
D-Wave Quantum Inc. Partners with South Korean Institutions to Boost Quantum Computing
D-Wave Quantum Inc. has entered into a memorandum of understanding with Yonsei University and Incheon Metropolitan City to foster quantum computing development in South Korea, marking a significant step towards the country's ambition to become a global leader in quantum technology.
Food Is Medicine Programs Show Promise in Improving Health Outcomes, More Research Needed
Recent findings highlight the potential of Food Is Medicine (FIM) programs to enhance diet quality and food security among individuals with chronic diseases, though further research is essential to understand their clinical impact fully.
Quantum BioPharma Ltd. Advances in Brain and Alcohol Health Research with Phase 2 Trial Approval
Quantum BioPharma Ltd. makes significant strides in its brain disorders and alcohol health pipeline, including Phase 2 trial approval for FSD202 and preparations for an IND filing for Lucid-MS, highlighting its commitment to addressing unmet medical needs.
NanoViricides' NV-387 Emerges as a Promising Broad-Spectrum Antiviral Against COVID-19 and Bird Flu
NanoViricides, Inc. highlights NV-387, its broad-spectrum antiviral candidate, as a potential game-changer in combating emerging COVID-19 variants and Bird Flu strains, showcasing its superior performance in animal models and readiness for cGMP manufacturing.
Cure Alzheimer’s Fund Honors Breakthrough Research with Jeffrey L. Morby Prize
The Cure Alzheimer’s Fund has awarded the Jeffrey L. Morby Prize to researchers Andrew S. Yoo and Zhao Sun for their innovative study on modeling late-onset Alzheimer’s disease, marking a significant step forward in understanding and potentially treating the condition.
Study Links Microplastic Pollution in Coastal Waters to Increased Risk of Cardiometabolic Diseases
Residents of U.S. coastal counties with high levels of microplastic pollution in nearby waters face significantly higher rates of Type 2 diabetes, coronary artery disease, and stroke, highlighting the potential public health crisis posed by plastic pollution.
Innovative Behavioral Health Research Project Launches in Ohio
A collaborative research project between Northwoods, Concord Counseling, and The Ohio State University aims to explore the benefits of Case Aide Services in behavioral health, potentially reducing staff burnout and improving service delivery.
Breakthrough in Spin Photonics Offers New Avenues for Optical Innovation
Researchers in China have developed a folded-path metasurface platform that overcomes bandwidth constraints in spin photonics, enabling independent dispersion and phase control of two opposite spin states for the first time.
Study Reveals Unchanged Prevalence of Psoriasis in the U.S., Highlights Need for Better Treatments
A recent study published in the Journal of American Academy of Dermatology shows the prevalence of psoriasis among U.S. adults remains steady at 3% over the last decade, underscoring the ongoing need for effective treatments and improved diagnostic access.
Soligenix Advances Treatment for Behçet’s Disease with New Clinical Trial
Soligenix Inc. has initiated a clinical trial for SGX945, a potential treatment for Behçet’s disease, a rare autoimmune disorder with limited treatment options, highlighting a significant step towards addressing the unmet needs of patients globally.
Quantum BioPharma Advances MS Research with Groundbreaking PET Imaging Study
Quantum BioPharma Ltd. has initiated a pioneering PET imaging study with Massachusetts General Hospital to track myelin integrity in multiple sclerosis patients, potentially revolutionizing treatment evaluation.
GeoVax's GEO-CM04S1 Shows Superior Immune Response in CLL Patients Compared to mRNA Vaccines
GeoVax Labs, Inc. reports that its GEO-CM04S1 vaccine has demonstrated superior T cell responses in chronic lymphocytic leukemia (CLL) patients compared to an authorized mRNA COVID-19 vaccine, highlighting potential advancements in protecting immunocompromised individuals.
Brisa Therapeutics Highlights Nature's Impact on Mental Wellness in Podcast Feature
Brisa Therapeutics discusses the therapeutic benefits of nature on mental and emotional health in a recent podcast episode, emphasizing the science behind how natural environments facilitate healing and nervous system regulation.
BiomX Inc. Achieves Breakthrough in Treating Antibiotic-Resistant Infections
BiomX Inc. has reported successful Phase 2 clinical trial results for treating diabetic foot bone infections and cystic fibrosis with bacteriophage therapy, offering a potential solution to the growing antibiotic resistance crisis.
Lantern Pharma Inc. Reports Complete Response in Advanced NSCLC Patient in HARMONIC(TM) Trial
Lantern Pharma Inc. (NASDAQ: LTRN) has reported a significant clinical outcome in its Phase 2 HARMONIC(TM) trial, showcasing the potential of its LP-300 treatment in combination with standard chemotherapy for never-smoker patients with advanced non-small cell lung cancer (NSCLC), marking a pivotal moment in oncology treatment.
Tonix Pharmaceuticals Reports Promising Phase 3 Results for Fibromyalgia Treatment
Tonix Pharmaceuticals Holding Corp. has unveiled positive Phase 3 trial data for TNX-102 SL, a potential breakthrough in fibromyalgia treatment, showcasing significant pain reduction and improved sleep quality, marking a significant advancement in pain management therapies.
GeoVax Gains EMA Support for Streamlined Mpox and Smallpox Vaccine Development
GeoVax Labs, Inc. receives favorable regulatory guidance from the European Medicines Agency, simplifying the development pathway for its GEO-MVA vaccine against Mpox and smallpox, marking a significant step towards addressing global vaccine shortages.
Creative Biolabs Enhances Non-IgG Antibody Development with Innovative Platform
Creative Biolabs introduces a groundbreaking platform for the development of non-IgG antibodies, addressing key challenges in yield, purification, and stability to unlock their therapeutic potential.
Electric Fields Found to Enhance Immune Response Against Glioblastoma
A recent study by the University of Southern California reveals that electric fields can significantly boost the immune system's fight against glioblastoma, offering hope for extended patient survival and new treatment avenues.
Cybin Inc. Advances Phase 3 Psychedelic Therapeutics Program, Signaling Progress in Mental Health Treatment
Cybin Inc. reports significant progress in its Phase 3 clinical trials for CYB003, a novel treatment for major depressive disorder, highlighting the potential of psychedelic therapeutics in addressing mental health conditions.
Utah's Life Sciences Sector Shines at BIO International Convention
BioUtah and partners showcase Utah's rapidly growing life sciences industry at the BIO International Convention, highlighting the state's collaborative ecosystem and business-friendly environment.
Webinar to Address Innovative Approaches in Preventing Violence Against Women
Footage Foundation and El-Agartuu are set to host a webinar discussing innovative methods and research findings on preventing violence against women, highlighting the need for compassionate, evidence-based strategies to address this global issue.
Prenatal Exposure to 'Forever Chemicals' Linked to Higher Blood Pressure in Teens
New research reveals that prenatal exposure to synthetic compounds known as 'forever chemicals' is associated with higher blood pressure in children, particularly during adolescence, highlighting the need for policy-level actions to reduce exposure.
Content Carnivores LLC to Showcase Global Life Sciences Innovations at BIO International Convention 2025
Content Carnivores LLC will participate in the BIO International Convention 2025, representing innovative life sciences companies from North America and Europe, highlighting Utah's growing life sciences sector and facilitating global partnerships.
Soligenix Inc. Advances Clinical Programs with Key Trial Results Expected by 2026
Soligenix Inc. is making significant progress in its clinical programs, with critical trial results for treatments of rare diseases like cutaneous T-cell lymphoma and Behçet’s disease expected in the coming years, highlighting the company's role in addressing unmet medical needs.
Study Reveals Accelerated Biological Aging in Children with Multiple Sclerosis
New research from UC San Diego indicates that children and adolescents with multiple sclerosis experience faster biological aging, highlighting the urgent need for targeted therapies.